DK1768657T3 - Fremgangsmåder og sammensætninger til at behandle ophthalmiske tilstande med retinylderivater - Google Patents

Fremgangsmåder og sammensætninger til at behandle ophthalmiske tilstande med retinylderivater

Info

Publication number
DK1768657T3
DK1768657T3 DK05758777T DK05758777T DK1768657T3 DK 1768657 T3 DK1768657 T3 DK 1768657T3 DK 05758777 T DK05758777 T DK 05758777T DK 05758777 T DK05758777 T DK 05758777T DK 1768657 T3 DK1768657 T3 DK 1768657T3
Authority
DK
Denmark
Prior art keywords
compositions
methods
ophthalmic conditions
treating ophthalmic
retinyl derivatives
Prior art date
Application number
DK05758777T
Other languages
Danish (da)
English (en)
Inventor
Kenneth Widder
Jay Lichter
Nathan L Mata
Original Assignee
Sirion Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34981643&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1768657(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sirion Therapeutics Inc filed Critical Sirion Therapeutics Inc
Application granted granted Critical
Publication of DK1768657T3 publication Critical patent/DK1768657T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/16—Ophthalmology
    • G01N2800/164—Retinal disorders, e.g. retinopathy

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK05758777T 2004-06-23 2005-06-06 Fremgangsmåder og sammensætninger til at behandle ophthalmiske tilstande med retinylderivater DK1768657T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US58229304P 2004-06-23 2004-06-23
US62969504P 2004-11-19 2004-11-19
US66090405P 2005-03-11 2005-03-11
US67240505P 2005-04-18 2005-04-18
PCT/US2005/020080 WO2006007314A1 (en) 2004-06-23 2005-06-06 Methods and compositions for treating ophthalmic conditions with retinyl derivatives

Publications (1)

Publication Number Publication Date
DK1768657T3 true DK1768657T3 (da) 2008-12-01

Family

ID=34981643

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05758777T DK1768657T3 (da) 2004-06-23 2005-06-06 Fremgangsmåder og sammensætninger til at behandle ophthalmiske tilstande med retinylderivater

Country Status (27)

Country Link
US (3) US8314152B2 (es)
EP (3) EP1768657B1 (es)
JP (1) JP4855396B2 (es)
KR (1) KR100862930B1 (es)
AR (1) AR049929A1 (es)
AT (1) ATE404188T1 (es)
AU (1) AU2005262558B8 (es)
BR (1) BRPI0512569A (es)
CA (1) CA2569691C (es)
CY (1) CY1110435T1 (es)
DE (1) DE602005008970D1 (es)
DK (1) DK1768657T3 (es)
EA (1) EA011864B1 (es)
ES (1) ES2313368T3 (es)
GE (1) GEP20084520B (es)
HK (1) HK1107671A1 (es)
IL (1) IL179872A (es)
LV (1) LV13564B (es)
MX (1) MXPA06014978A (es)
NO (1) NO20070408L (es)
NZ (1) NZ551955A (es)
PL (1) PL1768657T3 (es)
PT (1) PT1768657E (es)
SG (1) SG140607A1 (es)
SI (1) SI1768657T1 (es)
TW (1) TWI396532B (es)
WO (1) WO2006007314A1 (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004222279B2 (en) 2003-03-14 2010-01-21 University Of Washington Retinoid replacements and opsin agonists and methods for the use thereof
KR20060135819A (ko) 2004-02-17 2006-12-29 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 황반변성을 포함하는 안과질환의 관리
US7566808B2 (en) 2004-02-17 2009-07-28 President And Fellows Of Harvard College Management of ophthalmologic disorders, including macular degeneration
JP2007525496A (ja) * 2004-02-17 2007-09-06 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 黄班変性症を含む眼科疾患の管理
US7951841B2 (en) 2004-06-18 2011-05-31 University Of Washington Retinal derivatives and methods for the use thereof for the treatment of visual disorders
EP1768657B1 (en) 2004-06-23 2008-08-13 Sirion Therapeutics, Inc. Methods and compositions for treating ophthalmic conditions with retinyl derivates
US20060089411A1 (en) * 2004-08-07 2006-04-27 Gierhart Dennis L Treatment of Stargardt's disease and other lipofuscin disorders with combined retinaldehyde inhibitor and zeaxanthin
AU2005287343A1 (en) * 2004-08-18 2006-03-30 Sirion Therapeutics, Inc. Combination compositions comprising 13-cis-retinyl derivatives and uses thereof to treat opthalmic disorders
AU2005302554A1 (en) * 2004-10-28 2006-05-11 Idexx Laboratories, Inc. Compositions for controlled delivery of pharmaceutically active compounds
EP1807103A4 (en) * 2004-11-04 2009-02-11 Sirion Therapeutics Inc MODULATORS OF A COMPLEX RETINOL-RETINOL-BINDING PROTEIN-TRANSTHYRETINE FORMATION
EA011154B1 (ru) * 2004-12-08 2009-02-27 Сирион Терапьютикс, Инк. Композиции для лечения ретинол-ассоциированных заболеваний
UA81382C2 (en) * 2005-07-11 2007-12-25 Composition for treating retinol-related diseases by modulation of retinol binding
US8114440B2 (en) * 2005-11-16 2012-02-14 Idexx Laboratories Inc. Pharmaceutical compositions for the administration of aptamers
US7754679B2 (en) * 2005-11-16 2010-07-13 Idexx Laboratories, Inc. Pharmaceutical compositions for the administration of aptamers
WO2007150046A2 (en) * 2006-06-22 2007-12-27 Sirion Therapeutics, Inc Methods and compositions for treating ophthalmic conditions via modulation of megalin activity
US20100104644A1 (en) * 2006-07-27 2010-04-29 University Of Florida Research Foundation, Inc. Compositions and Methods for Treating or Preventing Ophthalmic Disease
WO2008013986A2 (en) * 2006-07-27 2008-01-31 University Of Florida Research Foundation, Inc. Compositions and methods for treating or preventing ophthalmic light toxicity
WO2008013983A2 (en) * 2006-07-27 2008-01-31 University Of Florida Research Foundation, Inc. Opsin stabilizing compounds and methods of use
US8828960B2 (en) * 2007-07-17 2014-09-09 Idexx Laboratories, Inc. Amino acid vitamin ester compositions for controlled delivery of pharmaceutically active compounds
CA2714530C (en) 2008-02-11 2018-09-25 University Of Washington Methods for the treatment and prevention of age-related retinal dysfunction
WO2009114136A2 (en) * 2008-03-12 2009-09-17 Albert Einstein College Of Medicine Of Yeshiva University Fenretinide derivatives and uses thereof as therapeutic, diagnostic and imaging agents
CA2730847A1 (en) * 2008-07-14 2010-01-21 Otonomy, Inc. Controlled-release apoptosis modulating compositions and methods for the treatment of otic disorders
WO2010129486A1 (en) * 2009-05-04 2010-11-11 Revision Therapeutics, Inc. Methods and compositions for treating ophthalmic conditions
IN2012DN00352A (es) 2009-06-16 2015-08-21 Bikam Pharmaceuticals Inc
WO2011034551A2 (en) 2009-09-15 2011-03-24 Qlt Inc. Pharmaceutical formulations comprising 9-cis-retinyl esters in a lipid vehicle
EP2509596B1 (en) 2009-12-08 2019-08-28 Case Western Reserve University Gamma aminoacids for treating ocular disorders
KR101851249B1 (ko) * 2010-04-19 2018-06-20 노벨리언 테라퓨틱스 인코포레이티드 내인성 레티노이드 결핍과 연관된 시각 장애의 치료 또는 완화를 위한 치료용 조성물, 제형 및 키트
AU2012346214B2 (en) 2011-11-30 2017-09-14 Bikam Pharmaceuticals, Inc. Opsin-binding ligands, compositions and methods of use
CA2862055C (en) * 2012-02-10 2020-03-10 Taiwan Liposome Company, Ltd. Pharmaceutical compositions to reduce complications of ocular steroid
NZ629267A (en) 2012-03-01 2016-11-25 Quadra Logic Tech Inc Therapeutic regimens and methods for improving visual function in visual disorders associated with an endogenous retinoid deficiency
US9011845B2 (en) 2012-06-26 2015-04-21 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Methods for treatment of inflammatory and infectious viral diseases
US8877183B2 (en) 2012-06-26 2014-11-04 National Institutes Of Health (Nih) Methods for treatment of ocular diseases
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics
US10092393B2 (en) 2013-03-14 2018-10-09 Allotex, Inc. Corneal implant systems and methods
WO2015184453A1 (en) * 2014-05-30 2015-12-03 Case Western Reserve University Retinylamine derivitives for treatment of ocular disorders
PT3210973T (pt) 2014-10-24 2021-02-12 Takeda Pharmaceuticals Co Compostos de heteroarilo para o tratamento de doenças oftálmicas
WO2016100972A2 (en) * 2014-12-19 2016-06-23 Kemin Industries, Inc. Intraocular delivery of bioactive molecules using iontophoresis
US10449090B2 (en) 2015-07-31 2019-10-22 Allotex, Inc. Corneal implant systems and methods
PL3416622T3 (pl) * 2016-02-15 2023-09-11 Kemin Industries, Inc. Dodatnio naładowane liposomy jako nośniki cząsteczek lipofilowych
US11395853B2 (en) * 2016-06-23 2022-07-26 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Biomimetic drug delivery of an immunomodulatory agent for the treatment of ocular conditions
CA3084568A1 (en) 2016-12-05 2018-06-14 The Jackson Laboratory Fat droplets in retina and optic nerve as a diagnostic marker for neurodegeneration and glaucoma in humans
US11931327B2 (en) 2017-07-04 2024-03-19 Daiichi Sankyo Company, Limited Drug for retinal degenerative disease associated with photoreceptor degeneration
JP2022531484A (ja) * 2019-05-06 2022-07-06 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 加齢性黄斑変性症を治療するための物質および方法

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4190594A (en) 1975-11-03 1980-02-26 Johnson & Johnson Retinoic acid derivatives
US4323581A (en) 1978-07-31 1982-04-06 Johnson & Johnson Method of treating carcinogenesis
US4665098A (en) 1985-03-28 1987-05-12 Mcneilab, Inc. Pharmaceutical composition of N-(4-hydroxyphenyl) retinamide having increased bioavailability
US4874795A (en) 1985-04-02 1989-10-17 Yesair David W Composition for delivery of orally administered drugs and other substances
US4673044A (en) * 1985-08-02 1987-06-16 Eastman Christensen Co. Earth boring bit for soft to hard formations
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US4682663A (en) * 1986-02-18 1987-07-28 Reed Tool Company Mounting means for cutting elements in drag type rotary drill bit
US4743400A (en) * 1986-09-22 1988-05-10 Mcneilab, Inc. Process for preparing retinoyl chlorides
AU6141490A (en) 1989-07-28 1991-03-11 Sloan-Kettering Institute For Cancer Research Growth factors containing vitamin a or other retinoids and uses thereof
US5814612A (en) * 1991-04-09 1998-09-29 Sloan-Kettering Institute For Cancer Research Retinol derivatives and uses thereof
US6992108B1 (en) * 1991-12-18 2006-01-31 The Salk Institute For Biological Studies Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
US6050354A (en) * 1992-01-31 2000-04-18 Baker Hughes Incorporated Rolling cutter bit with shear cutting gage
US5314909A (en) * 1993-03-17 1994-05-24 Merck & Co., Inc. Use of non-steroidal antiiflammatory agents in macular degeneration
US5399757A (en) * 1993-07-20 1995-03-21 Ortho Pharmaceutical Corporation Process for the preparation of N-(4-hydroxyphenyl)-retinamide
US5824685A (en) 1995-02-01 1998-10-20 The Johns Hopkins University School Of Medicine Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists
US5596011A (en) 1995-04-06 1997-01-21 Repine; Karen M. Method for the treatment of macular degeneration
US5702357A (en) * 1995-06-07 1997-12-30 Cobe Laboratories, Inc. Extracorporeal blood processing methods and apparatus
US5706906A (en) * 1996-02-15 1998-01-13 Baker Hughes Incorporated Superabrasive cutting element with enhanced durability and increased wear life, and apparatus so equipped
US5758733A (en) * 1996-04-17 1998-06-02 Baker Hughes Incorporated Earth-boring bit with super-hard cutting elements
US5846220A (en) * 1996-04-30 1998-12-08 Medtronic, Inc. Therapeutic method for treatment of Alzheimer's disease
US6034211A (en) * 1996-06-03 2000-03-07 Kelly; Jeffery W. β-sheet nucleating peptidomimetics
GB9621217D0 (en) * 1996-10-11 1996-11-27 Camco Drilling Group Ltd Improvements in or relating to preform cutting elements for rotary drill bits
AU5727798A (en) 1996-12-23 1998-07-17 Texas A & M University, The Anti-amyloidogenic agents
US5955305A (en) * 1997-04-28 1999-09-21 Incyte Pharmaceuticals, Inc. Human retinoid binding protein
US5776915A (en) * 1997-08-12 1998-07-07 Clarion Pharmaceuticals Inc. Phosphocholines of retinoids
WO1999008682A1 (en) 1997-08-15 1999-02-25 Duke University A method of preventing or treating estrogen-dependent diseases and disorders
CA2331620A1 (en) * 1998-05-11 1999-11-18 The Endowment For Research In Human Biology, Inc. Use of neomycin for treating angiogenesis-related diseases
US7229961B2 (en) * 1999-08-24 2007-06-12 Cellgate, Inc. Compositions and methods for enhancing drug delivery across and into ocular tissues
US6669951B2 (en) 1999-08-24 2003-12-30 Cellgate, Inc. Compositions and methods for enhancing drug delivery across and into epithelial tissues
PE20010647A1 (es) 1999-09-14 2001-06-23 Lilly Co Eli Moduladores de receptores de retinoide x (rxr) con perfil farmacologico mejorado
AU3082901A (en) 1999-11-23 2001-06-04 Gerhart Graupner Modulation of signal transduction
US20020031539A1 (en) * 2000-08-30 2002-03-14 The Brigham And Women's Hospital, Inc. Oxidized forms of retinoic acid as ligands for peroxisome proliferator activated receptor gamma
WO2002032413A2 (en) 2000-10-17 2002-04-25 Board Of Regents, The University Of Texas System A method to incorporate n-(4-hydroxyphenyl) retinamide in liposomes
US6408958B1 (en) * 2000-10-23 2002-06-25 Baker Hughes Incorporated Superabrasive cutting assemblies including cutters of varying orientations and drill bits so equipped
DE60136648D1 (de) 2000-12-05 2009-01-02 Los Angeles Childrens Hospital Pharmazeutische zusammensetzungen von fenretinid mit erhöhter bioverfügbarkeit und verfahren zu deren verwendung
US20030032078A1 (en) * 2001-01-23 2003-02-13 Board Of Regents, The University Of Texas System Methods and compositions for the treatment of macular and retinal degenerations
DE60234024D1 (de) 2001-05-29 2009-11-26 Chebigen Co Ltd Neue retinoidderivate und eine pharmazeutische anti-krebs-zusammensetzung, die diese verbindungen enthält
DE60208792T2 (de) * 2001-06-22 2006-08-31 Merck & Co., Inc. Tyrosin-kinase inhibitoren
WO2003003987A2 (en) 2001-07-06 2003-01-16 The Ohio State University Research Foundation Solid phase synthesis of arylretinamides
WO2003007944A1 (en) * 2001-07-20 2003-01-30 Qlt, Inc. Treatment of macular edema with photodynamic therapy
US20030229062A1 (en) 2001-12-07 2003-12-11 The Regents Of The University Of California Treatments for age-related macular degeneration (AMD)
US20040014131A1 (en) 2002-07-09 2004-01-22 Pfizer Inc. Assay methods
US7595430B2 (en) * 2002-10-30 2009-09-29 University Of Kentucky Research Foundation Methods and animal model for analyzing age-related macular degeneration
US7354574B2 (en) 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
WO2004050101A2 (en) 2002-11-29 2004-06-17 Gpc Biotech Ag Formulations useful against hepatitis c virus infections
SI21392A (sl) 2002-12-24 2004-06-30 Vinko Kunc Postopek za avtomatsko nastavitev ojačenja izpraševalnikovega sprejemnika v brezkontaktnem identifikacijskem sistemu
PT1594544T (pt) 2003-01-31 2016-07-14 Los Angeles Childrens Hospital Composições orais de fenretinida tendo biodisponibilidade aumentada e métodos de utilização das mesmas
FI20030426A (fi) 2003-03-24 2004-09-25 Tomi Jaervinen Syklodekstriinikompleksit
US7178609B2 (en) * 2003-08-19 2007-02-20 Baker Hughes Incorporated Window mill and drill bit
WO2005059564A1 (en) 2003-12-11 2005-06-30 Beth Israel Deaconess Medical Center, Inc. Rbp4 in insulin sensitivity/resistance, diabetes, and obesity
WO2005077176A1 (en) 2004-02-11 2005-08-25 The Trustees Of Columbia University In The City Of New York Anthocyanin compounds and methods of use thereof
US7566808B2 (en) 2004-02-17 2009-07-28 President And Fellows Of Harvard College Management of ophthalmologic disorders, including macular degeneration
KR20060135819A (ko) * 2004-02-17 2006-12-29 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 황반변성을 포함하는 안과질환의 관리
AU2005221283C1 (en) 2004-03-17 2011-02-03 Lars Michael Larsen Prevention of retinopathy by inhibition of the visual cycle
US7951841B2 (en) 2004-06-18 2011-05-31 University Of Washington Retinal derivatives and methods for the use thereof for the treatment of visual disorders
EP1768657B1 (en) 2004-06-23 2008-08-13 Sirion Therapeutics, Inc. Methods and compositions for treating ophthalmic conditions with retinyl derivates
US7286860B2 (en) 2004-07-23 2007-10-23 Dyna Llc Systems and methods for a comfortable wireless communication device
AU2005287343A1 (en) 2004-08-18 2006-03-30 Sirion Therapeutics, Inc. Combination compositions comprising 13-cis-retinyl derivatives and uses thereof to treat opthalmic disorders
EP1807103A4 (en) * 2004-11-04 2009-02-11 Sirion Therapeutics Inc MODULATORS OF A COMPLEX RETINOL-RETINOL-BINDING PROTEIN-TRANSTHYRETINE FORMATION
EA011154B1 (ru) 2004-12-08 2009-02-27 Сирион Терапьютикс, Инк. Композиции для лечения ретинол-ассоциированных заболеваний
UA81382C2 (en) * 2005-07-11 2007-12-25 Composition for treating retinol-related diseases by modulation of retinol binding

Also Published As

Publication number Publication date
CA2569691A1 (en) 2006-01-19
TW200612891A (en) 2006-05-01
EP2277516A1 (en) 2011-01-26
AU2005262558A1 (en) 2006-01-19
JP2008504257A (ja) 2008-02-14
BRPI0512569A (pt) 2008-03-25
SI1768657T1 (sl) 2009-02-28
EP2025336A1 (en) 2009-02-18
HK1107671A1 (en) 2008-04-11
US8314152B2 (en) 2012-11-20
IL179872A0 (en) 2007-05-15
EP1768657A1 (en) 2007-04-04
AU2005262558B8 (en) 2008-04-10
AR049929A1 (es) 2006-09-13
JP4855396B2 (ja) 2012-01-18
EA011864B1 (ru) 2009-06-30
WO2006007314A1 (en) 2006-01-19
ES2313368T3 (es) 2009-03-01
US20100298443A1 (en) 2010-11-25
KR20070074541A (ko) 2007-07-12
IL179872A (en) 2013-01-31
DE602005008970D1 (de) 2008-09-25
PT1768657E (pt) 2008-11-25
TWI396532B (zh) 2013-05-21
US20110294891A1 (en) 2011-12-01
AU2005262558B2 (en) 2008-03-20
EP1768657B1 (en) 2008-08-13
LV13564B (en) 2008-02-20
PL1768657T3 (pl) 2009-01-30
US20060167088A1 (en) 2006-07-27
NZ551955A (en) 2010-08-27
NO20070408L (no) 2007-03-20
CA2569691C (en) 2010-08-17
KR100862930B1 (ko) 2008-10-13
EA200700109A1 (ru) 2007-10-26
GEP20084520B (en) 2008-10-27
SG140607A1 (en) 2008-03-28
US8410168B2 (en) 2013-04-02
CY1110435T1 (el) 2015-04-29
MXPA06014978A (es) 2007-04-25
ATE404188T1 (de) 2008-08-15

Similar Documents

Publication Publication Date Title
DK1768657T3 (da) Fremgangsmåder og sammensætninger til at behandle ophthalmiske tilstande med retinylderivater
DK2952178T3 (da) Oftalmiske sammensætninger og fremgangsmåder til behandling af øjne
DK1765327T3 (da) Forbindelser, sammensætninger og fremgangsmåder
DK1954337T3 (da) Fremgangsmåde og apparat til injektion
DK1830838T3 (da) Sammensætninger og fremgangsmåder til behandling af neoplastiske sygdomme
DK1805312T3 (da) Fremgangsmåder og midler til fremstilling af hyaluronan
DE602005013859D1 (de) Schaukelvorrichtung zum Trainieren
DK1969391T3 (da) Tyndfilm emitter-absorber indretning og fremgangsmåde
DK1888033T3 (da) Fremgangsmåde og sammensætning til behandling af inflammatoriske sygdomme
DK1948852T3 (da) Hovedelektrode og fremgangsmåde til dannelse af hovedelektroden
DK1791852T3 (da) C-aryl glucosid -SGLT2-inhibitorer og metode til deres fremstilling
DK1838355T3 (da) Forbedrede quenching-fremgangsmåder til erytrocyt-inaktiveringsfremgangsmåde
DK2046362T3 (da) Formulering omfattende valleprotein og hydrolysater til forbedring af muskelrekuperation
DE602005005527D1 (de) Verschlussdüse
HK1121952A1 (en) Methods and compositions for treating conditions
DE602005019525D1 (de) Verschlussdüse
DK1709018T3 (da) Acylaminothiazolderivater og anvendelse deraf som beta-amyloid-hæmmere
DK1692102T3 (da) Sammensætninger og fremgangsmåder til at påvise og behandle sygdomme og tilstande knyttet til chemokinreceptorer
FI20055682A0 (fi) Läpivientiosa sekä menetelmä
DK1791423T3 (da) Sammensætninger og fremgangsmåder til behandling af hyperproliferative dermatologiske tilstande
DK1931379T3 (da) Proteiner med forbedret opløselighed samt fremgangsmåder til frembringelse og anvendelse af samme
NO322006B2 (no) Anordning og fremgangsmåte for brønnintervenering
NO20073582L (no) Sammensetninger og fremgangsmåter for behandling av schizofreni og beslektede tilstander
FR2866853B1 (fr) Methode et dispositif de controle du glissement
NO20050844D0 (no) Fremgangsmate og anordning for varmebalanse